Ideus v. Teva Pharmaceuticals USA, Inc., No. 19-1361 (8th Cir. 2021)Annotate this Case
Plaintiff file a products liability action against Teva, the manufacturer of intrauterine devices, after she suffered complications from the implantation of an intrauterine device that broke and embedded inside her uterus.
The Eighth Circuit affirmed the district court's grant of summary judgment to the manufacturer, holding that all Teva was required to do under Nebraska law was warn medical professionals like plaintiff's physician about the device's potential risks. The court explained that the Nebraska Supreme Court has indicated that it would follow the "overwhelming majority rule" and join other states in rejecting the prescription-contraceptives exception to the learned-intermediary doctrine.